Cytox Ltd, a British company developing non-invasive tools to identify patients at risk of Alzheimer’s disease and dementia, has recruited Ian Gilham as new chairman of its board. Dr Gilham has a long track record in the pharmaceutical industry, including as chief executive of Axis-Shield Ltd, is also non-executive chairman of Horizon Discovery Plc, genedrive plc and Biosurfit SA. Dr Gilham holds a PhD in biological sciences from the University of Bath.
Cytox announced the appointment on 8 January 2020
Copyright 2020 Evernow Publishing Ltd
